Emelia J Benjamin

Author PubWeight™ 985.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 56.72
2 Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 41.47
3 Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2011 31.98
4 Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2012 30.79
5 Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2013 28.02
6 Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 26.95
7 Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2014 22.74
8 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002 16.25
9 Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006 15.60
10 Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008 13.39
11 Obesity and the risk of heart failure. N Engl J Med 2002 12.58
12 Genome-wide association study of blood pressure and hypertension. Nat Genet 2009 11.54
13 Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012 11.32
14 The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013 10.43
15 Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002 10.37
16 Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2015 10.14
17 The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007 9.90
18 Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010 9.09
19 Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004 8.80
20 Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002 8.49
21 Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004 8.27
22 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010 7.54
23 Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003 7.47
24 Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009 7.27
25 Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004 7.12
26 Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003 6.83
27 Obesity and the risk of new-onset atrial fibrillation. JAMA 2004 6.73
28 Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014 6.55
29 C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012 6.39
30 Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012 6.24
31 Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013 6.13
32 Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012 6.01
33 Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008 5.89
34 Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation 2011 5.26
35 Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 2009 5.22
36 Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007 5.10
37 The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet 2007 5.02
38 Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004 4.92
39 The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012 4.87
40 Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004 4.85
41 Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009 4.78
42 A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 2003 4.77
43 Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008 4.69
44 Incidence and prognosis of syncope. N Engl J Med 2002 4.69
45 AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011 4.65
46 Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012 4.63
47 A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med 2008 4.61
48 Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2013 4.60
49 Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 2004 4.56
50 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010 4.56
51 Impact of obesity on plasma natriuretic peptide levels. Circulation 2004 4.46
52 Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006 4.36
53 Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007 4.16
54 Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003 4.09
55 Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005 4.08
56 Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010 3.97
57 Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 2009 3.81
58 National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005 3.77
59 Genome-wide association study of PR interval. Nat Genet 2010 3.73
60 Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012 3.71
61 Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011 3.68
62 Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 2008 3.56
63 Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 2009 3.55
64 Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2006 3.48
65 Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003 3.46
66 Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004 3.39
67 Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA 2011 3.34
68 C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 2005 3.31
69 Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006 3.15
70 Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet 2011 3.07
71 Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med 2010 3.05
72 Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007 3.04
73 Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet 2007 2.93
74 Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 2010 2.91
75 Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011 2.89
76 Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 2016 2.87
77 Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 2008 2.84
78 Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003 2.80
79 Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation 2017 2.76
80 Systemic inflammation and COPD: the Framingham Heart Study. Chest 2007 2.74
81 Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study. Circulation 2009 2.63
82 Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes 2012 2.61
83 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010 2.58
84 Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study. Eur Heart J 2004 2.58
85 Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2003 2.51
86 Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 2005 2.49
87 Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2013 2.47
88 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 2011 2.45
89 Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study. Circulation 2007 2.42
90 P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). Am J Cardiol 2011 2.39
91 Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation 2003 2.39
92 Atrial fibrillation: current knowledge and future directions in epidemiology and genomics. Circulation 2011 2.36
93 Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002 2.33
94 Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010 2.32
95 Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2009 2.27
96 Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. BMC Med Genet 2007 2.25
97 Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation 2008 2.22
98 Pulse pressure and risk of new-onset atrial fibrillation. JAMA 2007 2.20
99 Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol 2008 2.18
100 Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013 2.17
101 Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension 2008 2.14
102 Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002 2.13
103 Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 2004 2.13
104 Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study. Am J Epidemiol 2004 2.12
105 Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA 2009 2.10
106 Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol 2009 2.10
107 Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham Heart Study. Circulation 2010 2.07
108 Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2009 2.06
109 Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009 2.05
110 Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010 2.05
111 Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2007 2.02
112 Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation 2011 2.00
113 Relation of QRS width in healthy persons to risk of future permanent pacemaker implantation. Am J Cardiol 2010 1.97
114 QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm 2005 1.96
115 Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. Arterioscler Thromb Vasc Biol 2010 1.95
116 A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol 2010 1.95
117 Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012 1.95
118 Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007 1.93
119 Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 2007 1.93
120 Characteristics of Framingham offspring participants with long-lived parents. Arch Intern Med 2007 1.91
121 Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation 2010 1.90
122 Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am J Hum Genet 2012 1.90
123 Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension 2011 1.90
124 European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 2010 1.90
125 Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 2004 1.84
126 The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening. Ann Intern Med 2003 1.84
127 Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008 1.80
128 Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur Heart J 2010 1.80
129 Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function. Circulation 2006 1.78
130 CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 2005 1.76
131 Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation 2009 1.75
132 Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA 2010 1.75
133 Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol 2008 1.74
134 Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2010 1.70
135 Association of parental heart failure with risk of heart failure in offspring. N Engl J Med 2006 1.69
136 Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 2007 1.69
137 Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 2009 1.69
138 Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc 2005 1.68
139 Heritability and a genome-wide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: the Framingham Heart Study. Circulation 2005 1.68
140 Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation 2012 1.67
141 Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke 2009 1.66
142 Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007 1.65
143 A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci 2010 1.65
144 Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study. BMC Med Genet 2007 1.65
145 C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med 2007 1.64
146 Genetics of the Framingham Heart Study population. Adv Genet 2008 1.62
147 Epidemiology of left ventricular false tendons: clinical correlates in the Framingham Heart Study. J Am Soc Echocardiogr 2009 1.62
148 Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation 2010 1.62
149 Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology 2013 1.60
150 Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007 1.60
151 Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation 2004 1.59
152 Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol 2004 1.59
153 Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 2005 1.59
154 Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol 2002 1.58
155 Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm 2010 1.58
156 Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 2010 1.57
157 Life-course socioeconomic position and incidence of coronary heart disease: the Framingham Offspring Study. Am J Epidemiol 2009 1.57
158 Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J 2007 1.55
159 AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation 2009 1.54
160 A genome-wide association study of aging. Neurobiol Aging 2011 1.54
161 Genome-wide association studies of the PR interval in African Americans. PLoS Genet 2011 1.53
162 Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study. Psychosom Med 2007 1.53
163 Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet 2010 1.52
164 Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation 2006 1.51
165 Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation 2007 1.50
166 Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 2004 1.49
167 Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010 1.47
168 Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant 2010 1.46
169 Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes 2006 1.46
170 C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 2002 1.46
171 Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study. Am Heart J 2008 1.45
172 Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet 2008 1.44
173 Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors. Am Heart J 2013 1.43
174 Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study. Am J Cardiol 2002 1.43
175 Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 2003 1.42
176 Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation 2004 1.42
177 Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 2009 1.41
178 Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004 1.41
179 Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 2004 1.40
180 Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin 2009 1.38
181 Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study. Psychosom Med 2005 1.38
182 Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J 2004 1.37
183 Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation 2008 1.36
184 Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study. J Am Coll Cardiol 2005 1.35
185 P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol 2009 1.35
186 Multiple biomarkers and the risk of incident hypertension. Hypertension 2007 1.34
187 Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ Cardiovasc Genet 2010 1.33
188 Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation 2012 1.32
189 Social networks and inflammatory markers in the Framingham Heart Study. J Biosoc Sci 2006 1.31
190 Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community. Circulation 2010 1.30
191 Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 2009 1.28
192 Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovasc Res 2011 1.27
193 Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007 1.26
194 Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med 2005 1.26
195 Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 2008 1.26
196 Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study. Circulation 2010 1.25
197 Health insurance and cardiovascular disease risk factors. Am J Med 2010 1.25
198 Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life. Hypertension 2007 1.24
199 Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study. Circulation 2012 1.23
200 Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 2006 1.22
201 White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study). Am J Cardiol 2011 1.22
202 Association of educational level with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2006 1.21
203 CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Genet Med 2010 1.21
204 Life course socioeconomic position is associated with inflammatory markers: the Framingham Offspring Study. Soc Sci Med 2010 1.21
205 Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. J Am Soc Nephrol 2005 1.20
206 Relation of smoking status to a panel of inflammatory markers: the framingham offspring. Atherosclerosis 2008 1.20
207 The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. Circ Cardiovasc Genet 2009 1.19
208 Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension 2007 1.18
209 Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension 2006 1.18
210 Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2008 1.18
211 Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation 2012 1.17
212 Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation. Am J Cardiol 2012 1.17
213 Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study). Am J Cardiol 2004 1.17
214 Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) 2009 1.17
215 ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J Am Coll Cardiol 2009 1.16
216 Multimarker approach for the prediction of heart failure incidence in the community. Circulation 2010 1.15
217 Dietary factors and incident atrial fibrillation: the Framingham Heart Study. Am J Clin Nutr 2010 1.15
218 Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity (Silver Spring) 2009 1.14
219 Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality. Arterioscler Thromb Vasc Biol 2010 1.13
220 Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension 2004 1.13
221 Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis 2004 1.13
222 Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 2010 1.13
223 Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J Am Coll Cardiol 2010 1.12
224 Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study). Am J Cardiol 2011 1.12
225 P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol 2010 1.12
226 Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium. Circ Cardiovasc Genet 2011 1.11
227 The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol 2010 1.11
228 Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary. Circulation 2005 1.11
229 A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail 2010 1.11
230 Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation 2014 1.11
231 The role of arrhythmias in defining cardiac dysfunction during sepsis. Am J Respir Crit Care Med 2013 1.10
232 Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci. PLoS Genet 2011 1.10
233 Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). Am J Cardiol 2008 1.10
234 Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function. Eur Heart J 2009 1.10
235 A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2010 1.09
236 Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2012 1.09
237 An update on the prognosis of patients with atrial fibrillation. Circulation 2012 1.09
238 Relations of biomarkers representing distinct biological pathways to left ventricular geometry. Circulation 2008 1.09
239 P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey. Heart Rhythm 2010 1.09
240 Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur Heart J 2011 1.08
241 Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis 2008 1.08
242 Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007 1.08
243 Relation of season and temperature to endothelium-dependent flow-mediated vasodilation in subjects without clinical evidence of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2007 1.07
244 Atrial fibrillation in congestive heart failure. Heart Fail Clin 2010 1.07
245 Doppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study). Am J Cardiol 2003 1.06
246 Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet 2011 1.06
247 Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study. Obesity (Silver Spring) 2011 1.05
248 Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol 2013 1.05
249 Relations of inflammation and novel risk factors to valvular calcification. Am J Cardiol 2006 1.05
250 Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study. Circulation 2009 1.04
251 Reproducibility of speckle-tracking-based strain measures of left ventricular function in a community-based study. J Am Soc Echocardiogr 2013 1.03
252 Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study. Stroke 2005 1.03
253 Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis 2008 1.03
254 Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011 1.03
255 Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol 2014 1.02
256 Forward and backward wave morphology and central pressure augmentation in men and women in the Framingham Heart Study. Hypertension 2014 1.02
257 Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol 2010 1.01
258 Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women. Am J Hypertens 2005 1.00
259 Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens 2005 1.00
260 Mapping quantitative traits in unselected families: algorithms and examples. Genet Epidemiol 2009 1.00
261 Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol 2008 1.00
262 Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep 2006 0.99
263 Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. J Nutr 2012 0.99
264 Genome-wide scan for pulse pressure in the National Heart, Lung and Blood Institute's Framingham Heart Study. Hypertension 2004 0.99
265 Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age. Am J Cardiol 2009 0.99
266 Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Am Heart J 2007 0.99
267 Inflammatory markers and neuropsychological functioning: the Framingham Heart Study. Neuroepidemiology 2011 0.99
268 Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol 2004 0.98
269 Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort. Atherosclerosis 2004 0.98
270 Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol 2012 0.98
271 Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community. Circulation 2009 0.97
272 American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association. Circulation 2011 0.97
273 Age- and sex-based reference limits and clinical correlates of myocardial strain and synchrony: the Framingham Heart Study. Circ Cardiovasc Imaging 2013 0.97
274 Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. J Stroke Cerebrovasc Dis 2007 0.97
275 Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making? Circulation 2012 0.97
276 Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts. Circ Cardiovasc Genet 2012 0.97
277 Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J 2013 0.97
278 Consent for genetic research in the Framingham Heart Study. Am J Med Genet A 2010 0.96
279 Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 2008 0.95
280 Heritability, linkage, and genetic associations of exercise treadmill test responses. Circulation 2007 0.95
281 Next steps in cardiovascular disease genomic research--sequencing, epigenetics, and transcriptomics. Clin Chem 2011 0.95
282 Addition of inflammatory biomarkers did not improve diabetes prediction in the community: the framingham heart study. J Am Heart Assoc 2012 0.95
283 Vascular stiffness and genetic variation at the endothelial nitric oxide synthase locus: the Framingham Heart study. Hypertension 2007 0.94
284 Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk. Arterioscler Thromb Vasc Biol 2013 0.94
285 Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008 0.94
286 Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J 2011 0.94
287 Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail 2013 0.94
288 Aspirin use and cardiovascular events in social networks. Soc Sci Med 2012 0.93
289 Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Atherosclerosis 2008 0.93
290 Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Circulation 2007 0.93
291 Strategies to design and analyze targeted sequencing data: cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. Circ Cardiovasc Genet 2014 0.93
292 Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study. Stroke 2012 0.93
293 Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension 2003 0.92
294 Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care 2008 0.92
295 Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. Atherosclerosis 2013 0.92
296 Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. J Am Heart Assoc 2013 0.92
297 Brachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing. Vasc Med 2009 0.92
298 Clinical correlates of circulating visfatin levels in a community-based sample. Diabetes Care 2007 0.91
299 Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2007 0.90
300 Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing Group. Circulation 2005 0.89
301 Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Ethn Dis 2004 0.89
302 Vitamin D status is not related to development of atrial fibrillation in the community. Am Heart J 2011 0.89
303 Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc 2013 0.88
304 Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community. J Am Heart Assoc 2013 0.88
305 Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals. Circulation 2007 0.88
306 Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2014 0.87
307 Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study. Circ Cardiovasc Genet 2012 0.87
308 Vascular inflammation and sleep disordered breathing in a community-based cohort. Sleep 2013 0.87
309 Age-related changes in echocardiographic measurements: association with variation in the estrogen receptor-alpha gene. Hypertension 2007 0.87
310 Breastfeeding in infancy and adult cardiovascular disease risk factors. Am J Med 2009 0.87
311 Long-term C-reactive protein variability and prediction of metabolic risk. Am J Med 2009 0.87
312 P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol 2010 0.86
313 Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. Hum Mol Genet 2013 0.86
314 Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2013 0.86
315 The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans. Metabolism 2009 0.86
316 Association of matrix metalloproteinases with MRI indices of brain ischemia and aging. Neurobiol Aging 2009 0.86
317 Thyroid function and left ventricular structure and function in the Framingham Heart Study. Thyroid 2010 0.85
318 New-onset atrial fibrillation during hospitalization. J Am Coll Cardiol 2014 0.85
319 Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study. Am Heart J 2013 0.85
320 Thoracic periaortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function. Obesity (Silver Spring) 2013 0.84
321 Stroke risk in AF: do AF patterns matter? Eur Heart J 2010 0.84
322 Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015. J Am Heart Assoc 2015 0.84
323 Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the Framingham Heart Study. Echocardiography 2008 0.84
324 Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation. Europace 2010 0.84
325 Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. J Hypertens 2009 0.84
326 Triggers of MI for the individual and in the community. Lancet 2011 0.84
327 Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. Am J Hypertens 2004 0.83
328 Insulin resistance and atrial fibrillation (from the Framingham Heart Study). Am J Cardiol 2011 0.83
329 Challenges in the classification of atrial fibrillation. Nat Rev Cardiol 2010 0.83
330 Is baseline autonomic tone associated with new onset atrial fibrillation?: Insights from the framingham heart study. Ann Noninvasive Electrocardiol 2004 0.83
331 Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J 2012 0.83
332 Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study. J Stroke Cerebrovasc Dis 2008 0.83
333 The KCNMB1 E65K variant is associated with reduced central pulse pressure in the community-based Framingham Offspring Cohort. J Hypertens 2009 0.83
334 Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine. Circ Cardiovasc Genet 2014 0.83
335 Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study. Obesity (Silver Spring) 2014 0.83
336 Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet 2008 0.83
337 Common genetic variation at the endothelial nitric oxide synthase locus and relations to brachial artery vasodilator function in the community. Circulation 2005 0.82
338 Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans. Hum Genet 2014 0.82
339 Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study. Circ Cardiovasc Genet 2010 0.82
340 Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol 2004 0.82
341 Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women. Arterioscler Thromb Vasc Biol 2004 0.81
342 Short-term exposure to air pollution and digital vascular function. Am J Epidemiol 2014 0.81
343 Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study. J Am Heart Assoc 2013 0.81
344 Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Circ Cardiovasc Genet 2014 0.81
345 Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study. Diabetol Metab Syndr 2012 0.81
346 'Uncrunching' time: medical schools' use of social media for faculty development. Med Educ Online 2013 0.81
347 Association between SNP heterozygosity and quantitative traits in the Framingham Heart Study. Ann Hum Genet 2009 0.81
348 Left ventricular mechanical function: clinical correlates, heritability, and association with parental heart failure. Eur J Heart Fail 2014 0.81
349 Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study. Heart 2013 0.80
350 Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses. BMC Genet 2006 0.80
351 Aortic root diameter and longitudinal blood pressure tracking. Hypertension 2008 0.80
352 Cross-sectional correlates of serum heat shock protein 70 in the community. Am J Hypertens 2006 0.80
353 Atrial Fibrillation and Race - A Contemporary Review. Curr Cardiovasc Risk Rep 2013 0.80
354 Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample. Atherosclerosis 2008 0.79
355 Association of aortic valve calcium detected by electron beam computed tomography with echocardiographic aortic valve disease and with calcium deposits in the coronary arteries and thoracic aorta. Am J Cardiol 2004 0.79
356 Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation? J Am Coll Cardiol 2010 0.78
357 Genetic loci associated with atrial fibrillation: relation to left atrial structure in the Framingham Heart Study. J Am Heart Assoc 2014 0.78
358 Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study. Cardiovasc Ultrasound 2006 0.78
359 Aortic root remodeling and risk of heart failure in the Framingham Heart study. JACC Heart Fail 2013 0.78
360 Early-life antecedents of atrial fibrillation: place of birth and atrial fibrillation-related mortality. Ann Epidemiol 2011 0.78
361 Completion of guideline-recommended initial evaluation of atrial fibrillation. Clin Cardiol 2012 0.77
362 Circulating angiogenic cell populations, vascular function, and arterial stiffness. Atherosclerosis 2011 0.77
363 Cross-sectional relations of lipid concentrations to left ventricular structural attributes. Am J Cardiol 2010 0.77
364 Assessing the incremental predictive performance of novel biomarkers over standard predictors. Stat Med 2014 0.76
365 Association of parental hypertension with concentrations of select biomarkers in nonhypertensive offspring. Hypertension 2008 0.76
366 Early life predictors of atrial fibrillation-related mortality: evidence from the health and retirement study. Health Place 2013 0.76
367 2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 2016 0.75
368 Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest 2017 0.75
369 Where do we come from? Where are we going? Adverse outcomes in catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol 2014 0.75
370 Reply. J Hypertens 2016 0.75
371 Transfer function-derived central pressure and cardiovascular disease events: the Framingham Heart Study. J Hypertens 2016 0.75
372 Fifteen Genetic Loci Associated With the Electrocardiographic P Wave. Circ Cardiovasc Genet 2017 0.75
373 Global epidemiology of atrial fibrillation. Nat Rev Cardiol 2016 0.75
374 Global Health and Cardiovascular Disease. Circulation 2015 0.75
375 Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator? Circulation 2011 0.75
376 MicroRNA Signature of Cigarette Smoking and Evidence for a Putative Causal Role of MicroRNAs in Smoking-Related Inflammation and Target Organ Damage. Circ Cardiovasc Genet 2017 0.75
377 Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet 2017 0.75